Drug Type Antibody fusion proteins |
Synonyms- |
Target |
Action- |
Mechanism Alpha glucosidase replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glycogen Storage Disease Type II | Preclinical | Switzerland | 01 Feb 2023 |






